Life Spark editorial
Writing on survivorship, data ownership, and the clinician hand-off.
Short, plain-English essays. Every post is on-brand, cited to primary guidance (NCCN, ASCO, COG-LTFU) where applicable, and structured for both human readers and LLM-based search.
49 posts · page 1 of 7
- ·9 min read·clinician
Clinic operations
Telehealth Survivorship Follow-Up: What Works Remotely and What Still Needs a Room
A split-visit model for survivorship programs serving rural and travel-limited patients: what a video visit can carry, what testing must be local, and how to keep the surveillance cadence intact.
Read the post - ·7 min read·survivor
Clinic operations
Returning to Work After Cancer: Timing, Accommodations, and the Conversations to Plan
A practical, non-legal-advice guide to phased return, accommodation requests, disclosure choices, and the documentation your clinician can supply without exposing your full record.
Read the post - ·8 min read·both
Living well
Sleep After Cancer Treatment: Why Insomnia Persists and What Fixes It
Insomnia is one of the most common and most treatable survivorship symptoms, and it drives fatigue, mood, and cognition. What CBT-I involves, what to screen for first, and when to suspect apnea.
Read the post - ·7 min read·both
Clinic operations
Lymphedema After Cancer: Early Signs, Self-Checks, and the Referral That Should Not Wait
Lymphedema is easiest to control in the subclinical window, before visible swelling. Which surgeries and radiation fields raise risk, the self-check to run monthly, and the therapy referral trigger.
Read the post - ·8 min read·both
Cardio-oncology
Blood Pressure After Cancer Treatment: The Quietest Cardio-Oncology Risk Multiplier
Hypertension is the most modifiable amplifier of anthracycline, radiation, and VEGF-inhibitor cardiac risk. Targets, home-monitoring cadence, and why the survivorship threshold is stricter than the general one.
Read the post - ·8 min read·both
Late effects
Chemotherapy-Induced Peripheral Neuropathy: What Actually Helps Years Later
Numbness, burning, and balance loss after taxanes, platinums, or vinca alkaloids can persist for years. What the evidence supports, what to stop trying, and when the balance risk becomes the bigger problem.
Read the post - ·10 min read·clinician
Living well
Persistent Fatigue in Long-Term Survivors: What the Evidence Actually Supports
An evidence summary on cancer-related fatigue beyond five years — what to rule out, what the trial data supports for exercise, CBT-I, and psychostimulants, and where the evidence is thin.
Read the post - ·9 min read·clinician
Clinic operations
Hodgkin Lymphoma Late Effects Every Primary-Care Clinician Should Know
Mediastinal radiation and ABVD leave a predictable late-effect signature: premature coronary disease, valve disease, hypothyroidism, breast and lung second cancers. A primary-care surveillance map.
Read the post